SOURCE: CEGEDIM

May 14, 2007 02:52 ET

CEGEDIM: CONSOLIDATED TURNOVER - 1ST QUARTER 2007

PARIS -- (MARKET WIRE) -- May 14, 2007 -- Growth was robust at 8%

Paris, 14 May 2007 - CEGEDIM, the European leader in CRM and marketing studies for the pharmaceutical industry, posted consolidated turnover growth of 8% in the first quarter of 2007.

+------------------------+---------+---------+----------+----------------+
|Turnover in thousand    |   2007  |   2006  | Variation|  Organic growth|
|euros                   |         |         |          |                |
+------------------------+---------+---------+----------+----------------+
|CRM and strategic data  |   58,158|   55,369|       5 %|             5 %|
+------------------------+---------+---------+----------+----------------+
|Healthcare professionals|   35,760|   30,464|      17 %|             9 %|
+------------------------+---------+---------+----------+----------------+
|Healthcare insurance    |   19,307|   19,953|      -3 %|            -3 %|
|services                |         |         |          |                |
+------------------------+---------+---------+----------+----------------+
|Healthcare and strategic|  113,225|  105,786|       7 %|             5 %|
|data: A                 |         |         |          |                |
+------------------------+---------+---------+----------+----------------+
|Technologies and        |   22,826|   20,464|      12 %|            12 %|
|services: B             |         |         |          |                |
+------------------------+---------+---------+----------+----------------+
|Total: A + B            |  136,050|  126,250|       8 %|             6 %|
+------------------------+---------+---------+----------+----------------+
Like last year, first-quarter growth has been robust (+13% in 2006, +8% in 2007). Building on its excellent performance in the first quarter of 2006, the Group is off to another great start in 2007, with growth above the expected full-year pace.

The "CRM and strategic data" sector, which comprises businesses that cater to pharmaceutical companies, grew by 5%. The trends established in 2006 continued, confirming notably the momentum in international activities (+10%). As in the 1st quarter 2006, French businesses' turnover dropped somewhat, as expected (we note however that turnover for full year 2006 was stable). This sector did not benefit from any external growth this year, which makes its Q1 performance - in line with the 2006 trend of 5% full-year organic growth - particularly satisfactory.

The "Healthcare professionals" sector also maintained the trends it set in 2006, posting sales growth of 17% in the 1st quarter 2007. The acquisition of paramedical software publisher RM Ingénierie in France in early March 2006 and doctors' software publisher Stacks in Spain in late December 2006 contributed EUR 2.4million of this growth. Since 2006, this sector has been CEGEDIM Group's most dynamic, and its progress confirms the full-year growth outlook.

"Healthcare insurance services" turnover fell slightly over the quarter because certain contract signings were delayed relative to last year. It is likely to return to a slightly positive growth outlook over the course of the year.

"Technologies and services" activities experienced strong growth, due notably to the performance of Cegelease's financial lease business. The operation to deconsolidate most of Cegelease's debt was completed on 30 April 2007. The deal resulted in a cash injection of EUR 71million. The move will not have an impact on margins, which are already restated under IFRS. Apart from Cegelease, the "Technologies and services" sector posted moderate growth on a par with past performance.

2007 outlook

CEGEDIM Group confirms its consolidated full-year growth outlook of approximately 7%, not counting the acquisition of Dendrite, which became official on 9 May 2007 (see press releases dated 2 March and 9 May 2007), and not counting the sale of certain businesses to Tessi, which is still being negotiated (see press release dated 11 April 2007).

About CEGEDIM:

CEGEDIM develops exclusive databases and high value added software solutions. Its expertise falls into two divisions. The "Healthcare and strategic data" division comprises services specifically designed for pharmaceutical companies, healthcare professionals and health insurance providers. The "Technologies and services" division covers a variety of sectors.

Established as the European leader in its historic core business, CEGEDIM provides the world's largest pharmaceutical companies with vital support for successful CRM (Customer Relationship Management) and helps measure sales & marketing effectiveness. CEGEDIM's CRM tools, backed by the Group's powerful strategic databases, also provide its clients with a clearer picture of their markets and targets, optimizing both strategies and return on investment.

Founded in 1969, and the only European company operating globally in this market, CEGEDIM generated turnover of EUR 541 million in 2006 in 75 countries.

To learn more, please see our website: www.cegedim.com.

Listed on Eurolist by Euronext Paris, compartment B - ISIN FR0000053506 - Reuters CGDM.PA - Bloomberg CGM

+-------------------------+--------------------+
|Media inquiries          |Investor relations  |
+-------------------------+--------------------+
|CEGEDIM                  |             CEGEDIM|
+-------------------------+--------------------+
|Aude Balleydier          |   Sandrine Debroise|
+-------------------------+--------------------+
|Media Relations          |Chief Financial     |
|                         |Officer             |
+-------------------------+--------------------+
|Tel: + 33 (0)1 49 09 68  |Tel: + 33 (0)1 49 09|
|81                       |22 00               |
+-------------------------+--------------------+
|aude.balleydier@cegedim.f|investor.relations@c|
|r                        |egedim.fr           |
+-------------------------+--------------------+
|VP COMMUNICATION         |                    |
+-------------------------+--------------------+
|Coralie Voigt            |                    |
+-------------------------+--------------------+
|Press Officer            |                    |
+-------------------------+--------------------+
|Tel: + 33 (0)1 40 22 04  |                    |
|01                       |                    |
+-------------------------+--------------------+
|cvoigt@vp-communication.c|                    |
|om                       |                    |
+-------------------------+--------------------+
This information is provided by CompanynewsGroup

Contact Information